Sender Company & Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Buy
76,201
+33,087
+77% +$5.1M 6.79% 6
2025
Q4
$6.67M Sell
43,114
-24,240
-36% -$3.63M 3.11% 9
2025
Q3
$9.37M Buy
67,354
+32,703
+94% +$4.43M 1.03% 16
2025
Q2
$4.67M Buy
+34,651
New +$4.68M 1.32% 17
2025
Q1
Sell
-42,504
Closed -$5.85M 101
2024
Q4
$5.85M Buy
+42,504
New +$6.22M 5.31% 2

Other funds holding XLV

Sender Company & Partners's XLV Position: Q1 2026 in Review

Sender Company & Partners increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 77% in Q1 2026, buying an estimated $5.1M and bringing the position to 76,201 shares worth $11.2M. The position accounts for 6.79% of the portfolio, ranked #6.

Sender Company & Partners first reported a position in XLV in Q4 2024 and has held it in 5 quarters since. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Sender Company & Partners held 76,201 shares of State Street Health Care Select Sector SPDR ETF worth $11.2M as of Q1 2026.
  • Sender Company & Partners bought 33,087 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $5.1M.
  • State Street Health Care Select Sector SPDR ETF made up 6.79% of Sender Company & Partners's portfolio in Q1 2026, its #6 holding.
  • Sender Company & Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2024 and has held it in 5 quarters since.
  • 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Sender Company & Partners's 13F filing for Q1 2026, filed 15 May 2026.